Articles From: Steve Madden Announces Fourth Quarter and Fiscal Year 2014 Sales Results to uniQure Appoints Matthew Kapusta as Chief Financial Officer


2015/1/9
Steve Madden (Nasdaq:SHOO), a leading designer and marketer of fashion footwear and accessories for women, men and children, today announced preliminary sales results for the fourth quarter and fiscal year ended December 31, 2014 and updated its fiscal year 2014 EPS guidance.
Sign-up for Steve Madden Announces Fourth Quarter and Fiscal Year 2014 Sales Results investment picks
2015/1/9
Spectrum Brands Holdings, Inc. (NYSE: SPB) announced today that David R.
Sign-up for Dave Lumley, President and Chief Executive Officer of Spectrum Brands Holdings, Plans to Retire from the Company Before the End of 2015 investment picks
2015/1/9
Incyte Corporation (Nasdaq:INCY) and Agenus Inc. (Nasdaq:AGEN) today announced a global license, development and commercialization agreement focused on novel immuno-therapeutics using Agenus’ proprietary Retrocyte Display™ antibody discovery platform.
Sign-up for Incyte and Agenus Announce Global Alliance to Develop Novel Immuno-Oncology Antibodies investment picks
2015/1/9
MISSISSAUGA, ON , Jan.
Sign-up for Cipher Pharmaceuticals acquires assets of Melanovus Oncology Inc. investment picks
2015/1/9
Isis Pharmaceuticals, Inc. (Nasdaq:ISIS) and Alnylam Pharmaceuticals , Inc. (Nasdaq: ALNY), leaders in RNA-targeted therapeutics, announced today they have formed a new agreement, extending their existing strategic partnership – formed originally in 2004 – to lead the development and commercialization of RNA therapeutics.
Sign-up for Alnylam and Isis Form New Agreement, Extending Decade-Long Partnership for Leadership in RNA Therapeutics investment picks
2015/1/9
- Significantly Expands AMRI's Analytical Services Capabilities and Extends Drug Product Development Services to include Sterile Injectable Formulation Development - ALBANY, N.Y. , Jan.
Sign-up for AMRI to Acquire Aptuit Drug Product Development and Aseptic Clinical Manufacturing Businesses investment picks
2015/1/9
Findings from Phase 2b trial support clinical development of AGS-004 in adult eradication and pediatric studies.
Sign-up for Argos Therapeutics Provides Update on Clinical Research for Investigational Fully Personalized Immunotherapy for the Treatment of HIV investment picks
2015/1/9
CHICAGO, Jan.
Sign-up for Merge Healthcare to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/1/9
BEIJING , Jan.
Sign-up for Perfect World Special Committee Engages Financial Advisors and Legal Counsel investment picks
2015/1/9
By David Benoit and Jacob Bunge Nelson Peltz's investment firm launched a fight against DuPont Co.
Sign-up for Nelson Peltz demands 4 DuPont board seats investment picks
2015/1/9
By Carla Mozee, MarketWatch U.K. industrial production shrinks LONDON (MarketWatch) -- U.K. stocks fell Friday, with housing shares hit after a broker downgrade of the sector.
Sign-up for UPDATE: FTSE 100 dragged lower as downgrades hit housing shares, Tesco investment picks
2015/1/9
AVEO Oncology (NASDAQ:AVEO) today announced the appointment of Michael N.
Sign-up for AVEO Names Michael N. Needle, M.D., As Chief Medical Officer investment picks
2015/1/9
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that FoundationOne® , the company's flagship comprehensive genomic profile for patients with solid tumors, successfully identified clinically relevant genomic alterations in 65 percent of patients with lung adenocarcinoma whose tumors previously tested negative for alterations using multiple conventional approaches.
Sign-up for FoundationOne® Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer investment picks
2015/1/9
By Marek Fuchs, MarketWatch At this rate, Silicon Valley might be fully integrated within a century or so We had our last laugh of 2014, but the New Year started off on such solid road that laughs are certain to be scarce.
Sign-up for UPDATE: Intel takes a stand on diversity in the city of sin and showgirls investment picks
2015/1/9
By Barbara Kollmeyer, MarketWatch Critical information ahead of the U.S. market's open Back in black.
Sign-up for 'Ex-energy' to be investor catch-phrase as earnings roll around again investment picks
2015/1/9
TEL-AVIV, Israel, Jan.
Sign-up for RedHill Biopharma to Present at Biotech Showcase(TM) 2015 Conference in San Francisco investment picks
2015/1/9
Urges GFI Shareholders to Vote AGAINST the Inferior CME-GFI Transaction and Tender Their Shares to BGC NEW YORK , Jan.
Sign-up for BGC Files Preliminary Proxy Materials and Issues Letter to GFI Shareholders investment picks
2015/1/9
ADVISORY, Jan.
Sign-up for RAVE Restaurant Group, Inc. (Nasdaq: RAVE) to Ring The Nasdaq Stock Market Closing Bell investment picks
2015/1/9
LONDON, UNITED KINGDOM --
Sign-up for Land Securities Group PLC: Director Shareholding investment picks
2015/1/9
Inspired by the overwhelming success in New York City, prominent members of the African-American business communities in major cities across America have teamed with Paramount Pictures to create funds for students to see the Golden Globe-nominated film “SELMA” for free in participating theaters.
Sign-up for Cities Across America Are Joining the Movement – Due to the Reaction in New York City, Major U.S. Cities Are Inspired to Follow and Raise Funds for Students to See “SELMA” for Free investment picks
2015/1/9
HSINCHU, Taiwan , Jan.
Sign-up for ChipMOS REPORTS DECEMBER 2014 REVENUE; 4Q14 REVENUE AT THE HIGH-END OF GUIDANCE investment picks
2015/1/9
Penford Corporation (Nasdaq:PENX), a leader in ingredient systems for food and industrial markets, today reported first quarter fiscal 2015 results.
Sign-up for Penford Reports First Quarter Fiscal 2015 Financial Results investment picks
2015/1/9
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- European stocks fell Friday, moving lower following a report that staff at the European Central Bank have modeled a plan for the purchase of investment-grade assets by the central bank.
Sign-up for European stocks pull back after rally investment picks
2015/1/9
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- U.S. equity investors remained cautious in premarket trade on Friday, with stock futures moving lower ahead of the important nonfarm-payrolls numbers.
Sign-up for U.S. stocks: Futures in the red ahead of jobs report investment picks
2015/1/9
DUBLIN, Ireland , January 9, 2015 /PRNewswire/ -- - Expected to Create a Leader in Global Specialty Insurance and Reinsurance Markets - Expected to Create Double Digit EPS and Meaningful ROE Accretion XL Group plc (NYSE: XL) today announced that it has entered into an agreement under which XL will offer to acquire all of the capital stock of Catlin Group Limited (LSE: CGL) to form a combined business which is expected to have a leading presence in the global specialty insurance and reinsurance markets.
Sign-up for XL Group Plc Announces Acquisition of Catlin Group Limited investment picks
2015/1/9
By Sue Chang, MarketWatch SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Friday's session are Macy's Inc., Gap Inc., and Bed Bath & Beyond Inc. Macy's(M) said late Thursday it aims to save $140 million a year by restructuring its merchandising and marketing operations in a move that is likely to result in store closures.
Sign-up for UPDATE: Macy's, Gap, Bed Bath & Beyond in focus investment picks
2015/1/9
By Therese Poletti, MarketWatch Intel's CEO makes a bold proclamation about diversity SAN FRANCISCO (MarketWatch) -- The most interesting news at the Consumer Electronics Show wasn't a self-adjusting belt, a selfie-snapping drone, battery-powered roller skates or any other ludicrous gadget.
Sign-up for UPDATE: The most important thing unveiled at the CES has nothing to do with gadgets investment picks
2015/1/9
AMSTERDAM, the Netherlands, Jan.
Sign-up for uniQure Appoints Matthew Kapusta as Chief Financial Officer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Steve Madden Announces Fourth Quarter and Fiscal Year 2014 Sales Results to uniQure Appoints Matthew Kapusta as Chief Financial Officer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent